- Posaconazole Treatment in Korea: Single-Center Experience Over 5 Years
-
Lee HJ, Kwon JC, Kim SH, Choi SM, Lee DG, Park SH, Choi JH, Yoo JH, Cho BS, Lee S, Kim HJ, Min CK, Lee JW, Min WS
- KMID: 1793173
- Yonsei Med J.
- 2013 Sep;54(5):1234-1240.
- doi: 10.3349/ymj.2013.54.5.1234
PURPOSE: Posaconazole is a second-generation triazole with a broad spectrum. However, there is a lack of data to support a significant role for posaconazole in the treatment of invasive fungal... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Outcomes and Prognostic Factors of Empirical Antifungal Therapy with Itraconazole in the Patients with Hematological Malignancies: A Prospective Multicenter Observational Study in Korea
-
Kim JS, Cheong JW, Shin HJ, Lee JW, Lee JH, Yang DH, Lee WS, Kim H, Park JS, Kim SH, Kim YS, Kwak JY, Chae YS, Park J, Do YR, Min YH
- KMID: 1779880
- Yonsei Med J.
- 2014 Jan;55(1):9-18.
- doi: 10.3349/ymj.2014.55.1.9
PURPOSE: To identify prognostic factors for the outcomes of empirical antifungal therapy, we performed a multicenter, prospective, observational study in immunocompromised patients with hematological malignancies. MATERIALS AND METHODS: Three hundred seventy-six... -
- CITED
-
- Close
- SHARE
-
- Close
- Success Rate and Risk Factors for Failure of Empirical Antifungal Therapy with Itraconazole in Patients with Hematological Malignancies: A Multicenter, Prospective, Open-Label, Observational Study in Korea
-
Kim SJ, Cheong JW, Min YH, Choi YJ, Lee DG, Lee JH, Yang DH, Lee SM, Kim SH, Kim YS, Kwak JY, Park J, Kim JY, Kim HG, Kim BS, Ryoo HM, Jang JH, Kim MK, Kang HJ, Cho IS, Mun YC, Jo DY, Kim HY, Park BB, Kim JS
- KMID: 1796916
- J Korean Med Sci.
- 2014 Jan;29(1):61-68.
- doi: 10.3346/jkms.2014.29.1.61
We assessed the success rate of empirical antifungal therapy with itraconazole and evaluated risk factors for predicting the failure of empirical antifungal therapy. A multicenter, prospective, observational study was performed... -
- CITED
-
- Close
- SHARE
-
- Close
